W. Graninger

20.5k total citations
352 papers, 9.8k citations indexed

About

W. Graninger is a scholar working on Rheumatology, Epidemiology and Immunology. According to data from OpenAlex, W. Graninger has authored 352 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Rheumatology, 71 papers in Epidemiology and 69 papers in Immunology. Recurrent topics in W. Graninger's work include Systemic Lupus Erythematosus Research (42 papers), Rheumatoid Arthritis Research and Therapies (32 papers) and Antibiotics Pharmacokinetics and Efficacy (30 papers). W. Graninger is often cited by papers focused on Systemic Lupus Erythematosus Research (42 papers), Rheumatoid Arthritis Research and Therapies (32 papers) and Antibiotics Pharmacokinetics and Efficacy (30 papers). W. Graninger collaborates with scholars based in Austria, Germany and United States. W. Graninger's co-authors include Josef S Smolen, Martin Aringer, G Steiner, P Goldman, S J Korsmeyer, M Seto, Christian Dejaco, Elisabeth Presterl, Bernhard Parschalk and Martin Stradner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

W. Graninger

337 papers receiving 9.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
W. Graninger 2.4k 2.4k 1.9k 1.7k 1.5k 352 9.8k
Kar Neng Lai 1.7k 0.7× 2.1k 0.9× 1.9k 1.0× 2.2k 1.4× 1.1k 0.7× 354 12.9k
Tak Mao Chan 4.5k 1.8× 3.1k 1.3× 2.2k 1.2× 1.7k 1.0× 765 0.5× 442 13.2k
Xavier Bossuyt 1.6k 0.7× 2.4k 1.0× 2.1k 1.1× 1.3k 0.8× 684 0.4× 269 7.4k
Yoshiaki Ishigatsubo 1.5k 0.6× 2.2k 0.9× 973 0.5× 2.2k 1.3× 1.2k 0.8× 414 8.6k
Gordon W. Duff 2.0k 0.8× 5.1k 2.2× 2.3k 1.2× 2.6k 1.6× 550 0.4× 139 13.4k
Seymour Katz 1.1k 0.4× 4.1k 1.7× 2.5k 1.3× 1.3k 0.8× 1.1k 0.7× 248 11.0k
Werner J. Pichler 5.2k 2.1× 5.0k 2.1× 1.3k 0.7× 970 0.6× 2.3k 1.5× 366 20.1k
Shumpei Yokota 1.1k 0.5× 1.6k 0.7× 1.1k 0.6× 1.3k 0.8× 460 0.3× 302 6.5k
Heinz‐Peter Schultheiß 957 0.4× 1.5k 0.6× 2.0k 1.1× 3.5k 2.1× 769 0.5× 352 15.6k
Robert Wesley 1.2k 0.5× 1.6k 0.7× 3.0k 1.6× 1.6k 0.9× 1.1k 0.7× 158 13.7k

Countries citing papers authored by W. Graninger

Since Specialization
Citations

This map shows the geographic impact of W. Graninger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Graninger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Graninger more than expected).

Fields of papers citing papers by W. Graninger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Graninger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Graninger. The network helps show where W. Graninger may publish in the future.

Co-authorship network of co-authors of W. Graninger

This figure shows the co-authorship network connecting the top 25 collaborators of W. Graninger. A scholar is included among the top collaborators of W. Graninger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Graninger. W. Graninger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Husic, Rusmir, Philipp Bösch, Angelika Lackner, et al.. (2019). SAT0639 ACTIVE JAK/STAT SIGNALING IN CIRCULATING LEUCOCYTES DEFINES DISTINCT IMMUNOLOGIC ENDOTYPES OF RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 78. 1417–1417. 2 indexed citations
2.
Hermann, Josef, Rusmir Husic, Judith Gretler, et al.. (2016). THU0399 The Ankylosing Spondylitis Disease Activity Index (ASDAS) To Assess Disease Activity in Psoriatic Arthritis. Annals of the Rheumatic Diseases. 75. 332–333. 1 indexed citations
3.
Moazedi‐Fuerst, Florentine, Gerald Gruber, Martin Stradner, et al.. (2015). Effect of Laminin‐A4 inhibition on cluster formation of human osteoarthritic chondrocytes. Journal of Orthopaedic Research®. 34(3). 419–426. 10 indexed citations
4.
Deutsch, Alexander, et al.. (2012). Potential role of nuclear orphan receptors NR4A1 and NR4A3 in human chondrocytes. Osteoarthritis and Cartilage. 20. S140–S140.
5.
Steininger, Christoph, Monika Redlberger‐Fritz, W. Graninger, Michael Kundi, & Theresia Popow‐Kraupp. (2009). Near-patient assays for diagnosis of influenza virus infection in adult patients. Clinical Microbiology and Infection. 15(3). 267–273. 31 indexed citations
6.
Aringer, Martin, et al.. (2007). Long term safety and efficacy of open-label infliximab for SLE. Annals of the Rheumatic Diseases. 66. 455–455. 3 indexed citations
7.
Stradner, Martin, et al.. (2007). Spingosine-1-phosphate stimulates proliferation and counteracts interleukin-1 induced nitric oxide formation in articular chondrocytes. Osteoarthritis and Cartilage. 16(3). 305–311. 16 indexed citations
8.
Hermann, Josef & W. Graninger. (2006). Spondylarthropathien. PubMed. 1(1). 41–56.
9.
Yazdani‐Biuki, Babak, Josef Hermann, W. Graninger, et al.. (2004). Author's reply: Long term treatment of psoriatic arthritis with infliximab. Annals of the Rheumatic Diseases. 63(11). 1531–1532. 4 indexed citations
10.
Bobacz, Klaus, R. Maier, Christian Fialka, et al.. (2003). Is pro-matrix metalloproteinase-3 a marker for posttraumatic cartilage degradation?. Osteoarthritis and Cartilage. 11(9). 665–672. 14 indexed citations
11.
Graninger, W., Ojan Assadian, Heimo Lagler, & Michael Ramharter. (2002). The role of glycopeptides in the treatment of intravascular catheter-related infections. Clinical Microbiology and Infection. 8(5). 310–315. 18 indexed citations
12.
Erlacher, Ludwig, W. Graninger, Frank P. Luyten, Josef S Smolen, & Robert L. Ullrich. (1999). Zellbiologie des Chondrozyten im Hinblick auf die Arthroseentstehung: Rolle der knorpelspezifischen Wachstumsfaktoren Cartilage-Derived Morphogenetic Proteins. Journal für Kardiologie (Krause & Pachernegg GmbH). 6(2). 6–10. 1 indexed citations
13.
Brodowicz, Thomas, et al.. (1999). Persistent functional and social benefit 5 years after a multidisciplinary arthritis training program. Archives of Physical Medicine and Rehabilitation. 80(10). 1282–1287. 57 indexed citations
14.
Zimmermann, Christof, Josef S Smolen, W. Graninger, et al.. (1996). Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.. PubMed. 23(11). 1897–903. 23 indexed citations
15.
Laggner, A.N., M. Tryba, A. Georgopoulos, et al.. (1994). Oropharyngeal decontamination with gentamicin for long-term ventilated patients on stress ulcer prophylaxis with sucralfate?. PubMed. 106(1). 15–9. 34 indexed citations
16.
Frass, Michael, O. Traindl, Andrea Podolsky, C Leithner, & W. Graninger. (1991). [Comparison of netilmicin administration once or three times daily in intensive care patients].. PubMed. 103(4). 101–4. 3 indexed citations
17.
Lackner, F., W. Graninger, W. Ilias, Simon Panzer, & Eduard Schulz. (1990). Präoperative Eigenblutspende, der Einfluß von Hydroxyäthylstärke auf Retikuloendothelialsystem und Opsonine. Transfusion Medicine and Hemotherapy. 17(5). 276–279. 3 indexed citations
18.
Graninger, W., P Goldman, Cynthia C. Morton, Stephen J. O’Brien, & S J Korsmeyer. (1988). The kappa-deleting element. Germline and rearranged, duplicated and dispersed forms.. The Journal of Experimental Medicine. 167(2). 488–501. 48 indexed citations
19.
20.
Graninger, W., et al.. (1982). Staphylococcal scalded skin syndrome in an adult with fatal disseminated staphylococcal sepsis. Acta Dermato Venereologica. 62(4). 295–299. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kar Neng Lai Breakdown of academic impact, for papers by Tak Mao Chan Breakdown of academic impact, for papers by Xavier Bossuyt Breakdown of academic impact, for papers by Yoshiaki Ishigatsubo Breakdown of academic impact, for papers by Gordon W. Duff Breakdown of academic impact, for papers by Seymour Katz Breakdown of academic impact, for papers by Werner J. Pichler Breakdown of academic impact, for papers by Shumpei Yokota Breakdown of academic impact, for papers by Heinz‐Peter Schultheiß Breakdown of academic impact, for papers by Robert Wesley
Rankless by CCL
2026